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Abstract
Background: Ogilvie’s syndrome is described in the adult population, but rarely seen in children.
Case presentation: We present a case of a girl who suffered acute colonic pseudo-obstruction after laparoscopic
appendectomy.
Conclusions: Ogilvie’s syndrome, although rare in the pediatric population, should be considered as possible
diagnosis after a surgical procedure in presence of persisting subocclusive symptoms and radiological signs of
massive colonic dilatation without mechanical obstruction.
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Background
Ogilvie’s syndrome is a rare complication mostly de-
scribed in adult patients with severe underlying medical
or surgical conditions [1]. However, an increased num-
ber of cases of Ogilvie’s syndrome has been reported in
children with oncological diseases [2–5], after spinal sur-
gery [6], in sickle cell and Kawasaky disease [7, 8], and
after renal transplant [9].
We present a case of a girl who suffered acute colonic
pseudo-obstruction after laparoscopic appendectomy.
Case presentation
An 8-year-old girl, who had a laparoscopic appendec-
tomy for gangrenous appendicitis at another hospital,
presented with postoperative persisting non-bilious
vomiting and progressive abdominal distension initially
diagnosed as paralytic ileus and treated with conserva-
tive management. Despite this, her clinical condition did
not improve; she passed spontaneously flatus, but she
couldn’t have bowel movements without administration
of enemas. Laboratory findings were within normal
range. Ten days later, as the clinical conditions failed to
improve, she was transferred to our hospital.
On physical examination at admission, the abdomen
was distended and tympanitic to percussion, but soft with
no tenderness, rebound or guarding. Bowel sounds were
present. Laboratory findings were within normal range
and no free fluid or collections were found at the US scan.
The abdominal x-ray showed marked colonic gaseous
dilatation, without evidence of mechanical obstruction.
Gut decontamination with oral ciprofloxacin and metro-
nidazole was started and oral intake was progressively
resumed.
The symptoms improved temporarily, but, unfortu-
nately, they recurred 4 days after admission with greater
severity in presence of bilious vomiting. The abdominal
x-ray showed worsening colonic dilation (Fig. 1a) and
rectal stool impaction. Because of the diminished bowel
sounds, an abdominal computed tomography scan was
performed and confirmed the severe colonic dilatation
form the cecum to the splenic flexure in absence of co-
lonic mechanical obstruction (Fig. 1b). A nasogastric
tube and a rectal tube were inserted to put bowel at rest,
parenteral nutrition was started, the patient was kept on
nil by mouth and a combination of stool softeners and
enemas were administered. The clinical and radiological
findings suggested the diagnosis of Ogilvie’s syndrome.
Erythromicyn (250 mg two times a day) through the
nasogastric tube was then started followed by an im-
provement in clinical symptoms. The medication was
stopped after seven days. The patient made a full
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recovery, resuming her normal diet and spontaneous
bowel movements, and was discharged in good condi-
tions 25 days after the surgery. At the follow up appoint-
ment one week after discharge she was well and
completely recovered.
Discussion
Ogilvie’s syndrome, or acute colonic pseudo-obstruction,
is characterized by decreased gastrointestinal motility,
massive dilatation of the colon without signs of mechan-
ical obstruction, and limited small bowel involvement,
otherwise affected in postoperative adynamic ileum. It
occurs primarily in adult patients, whereas it happens
rarely in children. It has been suggested that it could be
the result of suppression of sacral parasympathetic
nerves’ activity together with an increase in sympathetic
impulses, resulting in inhibition of colonic motility and
hence in colonic dilatation [5, 6, 10]. Other pathogenetic
theories include prostaglandin E abnormalities, de-
creased splanchnic perfusion, side effects of neurotropic
medications, metabolic disorders affecting neuromuscu-
lar conduction (hypokalaemia, uremia) and herpes zoster
virus reactivation [10]. Patients present with recurrent
vomiting, nausea, abdominal pain and prominent ab-
dominal distension [6].
The syndrome tends to occur in adult patients with
serious medical and surgical conditions, as myocardial
infarction, neoplasia, metabolic disorders, spinal injury,
peritonitis, sepsis and shock. In pediatric population it
has been described in oncology patients, especially when
neutropenic and treated with high-dose vincristine [2–5]
in patients who underwent spinal surgery [6], after ad-
ministration of anticholinergic medication [11], in sickle
cell disease [7], in Kawasaky disease [8], and after renal
transplant [9].
There are no pathognomonic laboratory tests, but the
abdominal x-ray reveals large bowel dilatation, which es-
pecially involves cecum and ascending colon, with pres-
ervation of haustral markings and with little fluid in the
bowel lumen, in contrast to mechanical obstruction,
which contains multiple air/fluid levels. Computed tom-
ography imaging is more specific than plain radiography
to exclude any cause of mechanical obstruction and
often reveals proximal colonic dilatation with a transi-
tional zone adjacent to the splenic flexure.
Prompt diagnosis is essential to prevent the risk of is-
chemia, necrosis and, ultimately, perforation. Early man-
agement of Ogilvie’s Syndrome is conservative and
includes observation of the patient on bowel rest and nil
by mouth, parenteral nutrition, correction of fluid and
electrolyte imbalances, bowel decompression via naso-
gastric suction and rectal tube, administration of enemas
and promotility agents, limitation of narcotic medica-
tion. Close monitoring with frequent physical examin-
ation and eventually repeating of abdominal x-ray are
recommended in order to highlight changes in clinical
condition. If supportive therapy fails, once bowel perfor-
ation or ischemia have been ruled out, medical therapy
might be implemented. The motilin agonist erythro-
mycin stimulates gastric and small bowel motor activity
and induces smooth muscle contraction through a
nifedipine-sensitive mechanism. Given its use in children
Fig. 1 a Anterioposterior abdominal x-ray showing marked dilatation of the colon, without air/fluid levels and free air. b Coronal computed
tomography revealed massive dilatation of the large bowel with minimal involvement of the small bowel
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with gastrointestinal dysmotility, it may be a safe choice
for treatment of Ogilvie’s syndrome. However, the short
half-life of erythromycin and the rapid onset of tachy-
phylaxis might preclude its broad administration in this
syndrome [7, 12], with some evidence suggesting a lim-
ited efficacy on colonic motility [13].
The parasympathomimetic agent neostigmine has been
proved successful in treatment of Ogilvie’s syndrome in
adults and had been used in few cases also in children.
Through stimulation of the parasympathetic nervous sys-
tem, it increases colonic contractility. The side effects of
cholinesterase inhibitors include hypersalivation, nausea,
vomiting, abdominal pain, bradycardia, hypotension and
bronchospasm. During the infusion of neostigmine, pa-
tients should be monitored for possible development of
bradycardia or bronchospasm [4, 5, 7, 14].
In this case we empirically preferred to use Erythromi-
cin rather than neostigmine due to the better safety rec-
ord and ease of use, even in front of a controversial
literature on its efficacy. Limited evidence in the litera-
ture suggests that amoxicillin-clavulanate could be con-
sidered as an alternative [15].
If the conservative treatment failed to succeed, more ag-
gressive intervention, such as colonoscopic decompression
or surgery, are required to prevent perforation [4, 6, 10].
In our patient the diagnosis had not been immediately
suspected as paralytic ileum was the more obvious diagno-
sis after a surgical procedure. However, the scarce involve-
ment of the ileus and the massive colonic dilatation, not
typical of adynamic ileum, had suggested the correct
diagnosis.
Conclusions
Ogilvie’s syndrome is a rare condition in the pediatric
population. It mainly occurs in complex medical and
surgical patients, but it should be considered as possible
diagnosis after any surgery in case of persisting suboc-
clusive symptoms with radiological signs of massive co-
lonic dilatation in absence of mechanical obstruction.
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